
Potential anti-viral agents remdesivir, chloroquine/hydroxychloroquine, lopinavir-ritonavir and lopinavir-ritonavir with interferon will be evaluated as part of the trial, the Indian Council of Medical Research said on Wednesday.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2Ws8J2w
via
IFTTT
0 comments:
Post a Comment